Back
Regeneron Pharmaceuticals Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
$527.47
Seasonality Move:
8.37%
7 Day Trial
ALL ACCESS PASS
$
7
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 574.11 | Sell |
| 20-day SMA: | 575.27 | Sell |
| 50-day SMA: | 619.49 | Sell |
| 200-day SMA: | 830.42 | Sell |
| 8-day EMA: | 563.49 | Sell |
| 20-day EMA: | 578.84 | Sell |
| 50-day EMA: | 612.84 | Sell |
| 200-day EMA: | 758.46 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -15.45 | Sell |
| Relative Strength Index (14 RSI): | 35.08 | Sell |
| Chaikin Money Flow: | -1423383 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (551.56 - 594.96) | Sell |
| Bollinger Bands (100): | (602.96 - 719.14) | Sell |
Regeneron Pharmaceuticals Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 527.78 while REGN 8-day simple moving average is 574.11, which is a Sell signal.
-
The stock price of REGN is 527.78 while Regeneron Pharmaceuticals 20-day SMA is 575.27, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day simple moving average is 619.49 while REGN share price is 527.78, making it a Sell technically.
-
REGN stock price is 527.78 and Regeneron Pharmaceuticals 200-day simple moving average is 830.42, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $527.78. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
57B
Price in USD:
527.78
Share Volume:
1.5M
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
520.50
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?The Regeneron Pharmaceuticals stock price is 527.78 USD today.
-
Will REGN stock go up or go down?Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Regeneron Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 527.78 while REGN 8-day exponential moving average is 563.49, which is a Sell signal.
-
The stock price of REGN is 527.78 while Regeneron Pharmaceuticals 20-day EMA is 578.84, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day exponential moving average is 612.84 while REGN share price is 527.78, making it a Sell technically.
-
REGN stock price is 527.78 and Regeneron Pharmaceuticals 200-day simple moving average is 758.46, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.40 per share, an increase next quarter of $0.06 per share, a decrease this year of $9.13 per share, and an increase next year of $4.61 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
-
REGN Moving Average Covergence Divergence (MACD) indicator is -15.45, suggesting Regeneron Pharmaceuticals is a Sell
-
Regeneron Pharmaceuticals Relative Strength Index (RSI) is 35.08, which suggest Regeneron Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Regeneron Pharmaceuticals is (551.56 - 594.96), which suggest Regeneron Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Regeneron Pharmaceuticals is (602.96 - 719.14), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.